Company Info
Phone(858) 952-5500
Year Established
2006
Contacts
A. Rachel Leheny, Ph.D.CEO
Michael J. Dunn, MBA
President & COO
Eric W. Roberts
CBO
Sudarshan Hebbar, M.D.
CMO
Kenneth A. Stauderman, Ph.D.
Co-Founder & CSO
Daniel Geffken, MBA
Interim CFO
John M. Dunn
General Counsel
Company Description
CalciMedicaﾒs lead clinical compound, Auxora, is a potent and selective small molecule inhibitor of Orai1-containing CRAC channels that is being developed for use in patients with acute pancreatitis and accompanying systemic inflammatory response syndrome (SIRS) and in patients with COVID-19 pneumonia.